Cargando…

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement( )

This 2022 European Atherosclerosis Society lipoprotein(a) [Lp(a)] consensus statement updates evidence for the role of Lp(a) in atherosclerotic cardiovascular disease (ASCVD) and aortic valve stenosis, provides clinical guidance for testing and treating elevated Lp(a) levels, and considers its inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kronenberg, Florian, Mora, Samia, Stroes, Erik S G, Ference, Brian A, Arsenault, Benoit J, Berglund, Lars, Dweck, Marc R, Koschinsky, Marlys, Lambert, Gilles, Mach, François, McNeal, Catherine J, Moriarty, Patrick M, Natarajan, Pradeep, Nordestgaard, Børge G, Parhofer, Klaus G, Virani, Salim S, von Eckardstein, Arnold, Watts, Gerald F, Stock, Jane K, Ray, Kausik K, Tokgözoğlu, Lale S, Catapano, Alberico L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Special Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639807/ https://www.ncbi.nlm.nih.gov/pubmed/36036785 http://dx.doi.org/10.1093/eurheartj/ehac361

Ejemplares similares

High-density lipoprotein revisited: biological functions and clinical relevance
por: von Eckardstein, Arnold, et al.
Publicado: (2022)

Transatlantic Lipid Guideline Divergence: Same Data But Different Interpretations
por: Orringer, Carl E., et al.
Publicado: (2020)

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
por: Ginsberg, Henry N, et al.
Publicado: (2021)

Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
por: Mach, François, et al.
Publicado: (2018)

Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration
por: Ference, Brian A, et al.
Publicado: (2018)

Lipoprotein(a) as a cardiovascular risk factor: current status
por: Nordestgaard, Børge G., et al.
Publicado: (2010)

2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance
por: Cuchel, Marina, et al.
Publicado: (2023)

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
por: Stroes, Erik S., et al.
Publicado: (2015)

The spoils of war and the long-term spoiling of health conditions of entire nations
por: Navarese, Eliano P., et al.
Publicado: (2022)

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
por: Chapman, M. John, et al.
Publicado: (2011)

Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap
por: Parhofer, Klaus G, et al.
Publicado: (2020)

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
por: Ference, Brian A., et al.
Publicado: (2017)

Monocyte and haematopoietic progenitor reprogramming as common mechanism underlying chronic inflammatory and cardiovascular diseases
por: Hoogeveen, Renate M, et al.
Publicado: (2018)

Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines: A Systematic Review
por: Bruckert, Eric, et al.
Publicado: (2020)

Apolipoprotein(a) Inhibits In Vitro Tube Formation in Endothelial Cells: Identification of Roles for Kringle V and the Plasminogen Activation System
por: Liu, Lei, et al.
Publicado: (2013)

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
por: Borén, Jan, et al.
Publicado: (2020)

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease : Consensus Statement of the European Atherosclerosis Society
por: Nordestgaard, Børge G., et al.
Publicado: (2013)

Reflections from ACC 2015
por: Tokgözoğlu, Lale
Publicado: (2015)

Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis
por: Zheng, Kang H., et al.
Publicado: (2019)

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
por: Cuchel, Marina, et al.
Publicado: (2014)

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
por: Nurmohamed, Nick S, et al.
Publicado: (2023)

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
por: Ballantyne, Christie M, et al.
Publicado: (2019)

Highlights form ESC 2015
por: Tokgözoğlu, Prof. Lale
Publicado: (2015)

Apolipoprotein(a) stimulates nuclear translocation of β-catenin: a novel pathogenic mechanism for lipoprotein(a)
por: Cho, Taewoo, et al.
Publicado: (2013)

Highlights from ACC 15 Scientific Sessions: Part 1
por: Kaymaz, Cihangir, et al.
Publicado: (2015)

Highlights from ACC 15 Scientific Sessions: Part 2
por: Kaymaz, Cihangir, et al.
Publicado: (2015)

What do the “new” Pulmonary Hypertension Guidelines tell us: should we change our practice?
por: Kaymaz, Cihangir, et al.
Publicado: (2016)

Current Treatment Options in Homozygous Familial Hypercholesterolemia
por: Kayikcioglu, Meral, et al.
Publicado: (2022)

Comparison of Current International Guidelines for the Management of Dyslipidemia
por: Aygun, Sevda, et al.
Publicado: (2022)

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
por: Wiegman, Albert, et al.
Publicado: (2015)

Correction to: Role of Bempedoic Acid in Clinical Practice
por: Ballantyne, Christie M., et al.
Publicado: (2021)

Role of Bempedoic Acid in Clinical Practice
por: Ballantyne, Christie M., et al.
Publicado: (2021)

Pre- and in-hospital antithrombotic management patterns and in-hospital outcomes in patients with acute coronary syndrome: data from the Turkish arm of the EPICOR study
por: Ertaş, Fatih Sinan, et al.
Publicado: (2016)

Current perspectives on the use of statins in the treatment of dyslipidaemic patients: focus on pitavastatin
por: Tokgözoglu, Lale, et al.
Publicado: (2020)

Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9
por: Romagnuolo, Rocco, et al.
Publicado: (2017)

The landscape of preventive cardiology in Turkey: Challenges and successes
por: Tokgozoglu, Lale, et al.
Publicado: (2021)

Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis
por: Kaiser, Yannick, et al.
Publicado: (2022)

Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries
por: Rosenson, Robert S., et al.
Publicado: (2017)

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
por: Nordestgaard, Børge G., et al.
Publicado: (2016)

Impact of the COVID-19 pandemic in patients with a previous history of premature myocardial infarction
por: Kayikcioglu, Meral, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5fnjhufumero5q6sjsrbggo5pe